AVM Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- AVM Biotechnology's estimated annual revenue is currently $1.4M per year.
- AVM Biotechnology's estimated revenue per employee is $77,500
Employee Data
- AVM Biotechnology has 18 Employees.
- AVM Biotechnology grew their employee count by -10% last year.
AVM Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP IR | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Research Lab Director | Reveal Email/Phone |
4 | Director Information Technology | Reveal Email/Phone |
5 | President / Chief Administrative Officer | Reveal Email/Phone |
6 | Laboratory Director | Reveal Email/Phone |
7 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
8 | Director Communications & Business Development | Reveal Email/Phone |
9 | Operations Manager | Reveal Email/Phone |
10 | President and CSO | Reveal Email/Phone |
AVM Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is AVM Biotechnology?
AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 triggers the production and release of endogenous gamma delta+ Natural Killer T cells and could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology. The company is committed to developing products that improve outcomes without additional suffering because side effects from treatments should never be worse than the diseases themselves.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$1.4M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 18 | -5% | N/A |
#2 | $1.3M | 18 | 0% | $122.4M |
#3 | $2.3M | 18 | 0% | N/A |
#4 | $3.5M | 18 | 0% | N/A |
#5 | $1.7M | 18 | -5% | N/A |